References
- Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22:1393–1398.
- Wurm FM, Hacker D. First CHO genome. Nat Biotechnol. 2011;29:718–720.
- Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012;93:917–930.
- Fischer S, Handrick R, Otte K. The art of CHO cell engineering: A comprehensive retrospect and future perspectives. Biotechnol Adv. 2015; 33:1878–1896.
- Wilson C, Bellen HJ, Gehring WJ. Position effects on eukaryotic gene expression. Annu Rev Cell Biol. 1990;6:679–714.
- Lee JS, Kallehauge TB, Pedersen LE. Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway. Sci Rep. 2015 [cited 2019 Jan 07];5:8572.
- Sturtevant AH. The effects of unequal crossing over at the bar locus in Drosophila. Genetics. 1925;10:117–147.
- Gierman HJ, Indemans MH, Koster J. Domain-wide regulation of gene expression in the human genome. Genome Res. 2007;17:1286–1295.
- Jakočiūnas T, Jensen MK, Keasling JD. CRISPR/Cas9 advances engineering of microbial cell factories. Metab Eng. 2016;34:44–59.
- Lee JS, Grav LM, Pedersen LE. Accelerated homology-directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR/Cas9 and fluorescent enrichment. Biotechnol Bioeng. 2016;113:2513–2518.
- de Vree PJP, de Wit E, Yilmaz M, et al. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat Biotechnol. 2014;32:1019–1025.
- Gaidukov L, Wroblewska L, Teague B, et al. A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res. 2018;46:4072–4086.
- Zhang JJ, Liu KD, Qian K, et al. Construction of CHO cell stably expressing GLP-1 analogue and study of its culture process. China Biotechnol. 2017;37:52–58.
- Laufs S, Gentner B, Nagy KZ, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood. 2003;101:2191–2198.
- Silvers RM, Schowalter M, Litwin S, et al. Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein. Human Gene Ther. 2010;21:337–349.
- Zanatta DB, Tsujita M, Borelli P, et al. Genetic barcode sequencing for screening altered population dynamics of hematopoietic stem cells transduced with lentivirus. Mol Ther Methods Clin Dev. 2014;1:14052. [cited 2019 Jan 07];
- Kaas C, Kristensen C, Betenbaugh MJ, et al. Sequencing the CHO DXB11 genome reveals regional variations in genomic stability and haploidy. BMC Genomics. 2015 [cited 2019 Jan 07];16:1391.
- Nightingale SJ, Hollis RP, Pepper KA, et al. Transient gene expression by nonintegrating lentiviral vectors. Mol Ther. 2006;13:1121–1132.
- Gilbert LA, Horlbeck MA, Adamson B, et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell. 2014;159:647–661.
- Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84–87.
- Wang T, Wei JJ, Sabatini DM, et al. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014 343:80–84.
- Kim M, O'Callaghan PM, Droms KA, et al. A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol Bioeng. 2011;108:2346–2434.